Position in GH
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$4,811,737
-$895,029 QoQ
Shares Held
52,092
-6.8% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026Pathstone Holdings, LLC holds $130,287,723 across 21 Diagnostics & Research names. GH ranks #7 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
189,279 | $35,887,297 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
70,197 | $34,503,930 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
19,494 | $10,953,482 | |
| 4 | DGX |
Quest Diagnostics Inc
|
31,677 | $6,208,057 | |
| 5 | NTRA |
Natera, Inc.
|
24,436 | $4,886,954 | |
| 6 | ILMN |
Illumina, Inc.
|
39,311 | $4,845,472 | |
| 7 | GH |
Guardant Health, Inc.
This page
|
52,092 | $4,811,737 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
2,941 | $3,709,188 |
All Filings in GH
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,811,737 | 52,092 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $5,706,766 | 55,872 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,163,862 | 50,638 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,286,219 | 24,716 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $323,632 | 7,597 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $219,165 | 7,174 | Shares | Defined | 2025-02-14 | |
| 2023-12-31 | $217,805 | 8,052 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||